Reactions of 1,3-benzothiazines and 1,4-benzothiazepines
435
Methyl (Z)-(8,9-dimethoxy-1-phenyl-2-oxo-5H-pyrrolo-
[1,2-c][1,3]benzothiazin-3(2H)-ylidene)acetate
(7c, C22H19NO5S)
(s, H-5), 6.55 (d, J = 13.5 Hz, CH2, 1H), 5.81 (s, =CH–),
4.65 (d, J = 13.5 Hz, CH2, 1H), 3.89 (s, OMe pos. 7), 3.79
(s, OMe pos. 6), 3.73 (s, OMe ester group) ppm; 13C NMR
(80 MHz, CDCl3): d = 166.6 (C=O ester), 164.7 (C=O
lactone), 150.4 (quaternary C in heteroring), 150.3 (C-7),
147.0 (C-6), 134.0 (C-60, 2-chlorophenyl), 133.7 (C-20, 2-
chlorophenyl), 133.6 (C-10, 2-chlorophenyl), 132.8 (C-50,
2-chlorophenyl), 132.6 (C-40, 2-chlorophenyl), 131.5 (C-30,
2-chlorophenyl), 124.3 (C-8a), 122.5 (C-4a), 112.5 (C-8*),
108.8 (C-5*), 96.0 (C-4), 91.1 (=CH-), 56.0 (OMe, pos. 7),
55.9 (OMe, pos. 6), 51.5 (OMe ester), 43.6 (C-2) ppm
(*interchangeable assignments); IR (KBr): vꢀ = 1,798
1
M.p.: 226–228 °C (from methanol); yield 71%; H NMR
(250 MHz, CDCl3): d = 7.40–7.20 (5H, m, Ph), 6.85 (s, H-
5*), 6.82 (s, H-8*), 6.14 (s, =CH–), 5.56 (s, CH2), 3.91 (s,
OMe pos. 7), 3.80 (s, OMe pos. 6), 3.23 (s, OMe ester
group) ppm (*interchangeable assignments); 13C NMR
(80 MHz, CDCl3): d = 185.2 (C=O ketone), 166.5 (C=O
ester), 158.1 (C-4), 151.7 (C-7), 146.9 (C-6), 140.3
(quaternary C in heteroring), 131.3 (C40, phenyl), 130.1
(C-20,60, phenyl), 129.7 (C-8a), 128.6 (C-30,50, phenyl),
127.3 (C-10, phenyl), 117.2 (C-4a), 113.8 (C-8*), 111.8
(=C-R), 111.0 (C-5*), 98.5 (=CH– exocyclic group), 56.0
(OMe pos. 7), 54.9 (OMe pos. 6), 52.0 (OMe ester), 45.0
(C-2) ppm (*interchangeable assignments); IR (KBr):
(C=O lactone), 1,694 (C=O ester), 1,645 (C=C) cm-1
.
Methyl (Z)-[8,9-dimethoxy-10b-(4-nitrophenyl)-2-oxo-
5H,10bH-oxazolo[3,2-c][1,3]benzothiazin-3(2H)-ylidene]-
acetate (14f, C21H18N2O8S)
vꢀ = 1,701 (C=O ester), 1,675 (C=O ketone) cm-1
.
1
M.p.: 176–177 °C (from methanol); yield 69%; H NMR
(250 MHz, CDCl3): d = 8.26 (d, J = 9 Hz, H-20,60,
4-nitrophenyl), 7.54 (d, H-30,50, 4-nitrophenyl), 6.72 (s,
H-8), 6.65 (s, H-5), 6.32 (d, J = 13.5 Hz, CH2, 1H), 5.86
(s, =CH–), 4.75 (d, J = 13.5 Hz, CH2, 1H), 3.90 (s, OMe
pos. 7), 3.78 (s, OMe pos. 6), 3.74 (s, OMe ester group)
ppm; 13C NMR (80 MHz, CDCl3): d = 166.2 (C=O ester),
164.1 (C=O lactone), 150.5 (quaternary C in heteroring),
148.7 (C-7), 147.5 (C-6), 144.8 (C-40, 4-nitrophenyl), 134.3
(C-10, 4-nitrophenyl), 128.8 (C-20,60, 4-nitrophenyl), 124.6
(C-8a), 123.7 (C-30,50, 4-nitrophenyl), 121.7 (C-4a), 112.0
(C-8*), 109.4 (C-5*), 94.9 (C-4), 93.2 (=CH-), 56.0 (OMe
pos. 6 and 7, overlapping signals), 51.7 (OMe ester), 44.3
(C-2) ppm (*interchangeable assignments); IR (KBr):
vꢀ = 1,804 (C=O lactone), 1,692 (C=O ester), 1,649 (C=C)
Methyl (Z)-(5,6-dihydro-9,10-dimethoxy-2-oxopyrrolo-
[1,2-d][1,4]benzothiazepin-3(2H)-ylidene)acetate
(7d, C17H17NO5S)
M.p.: 190–191 °C (from methanol/acetone); yield 74%; 1H
NMR (250 MHz, CDCl3): d = 7.28 (s, H-5), 7.15 (s, H-8),
6.04 (s, =CH– heteroring), 5.48 (s, =CH–), 4.16 (triplet-
like signal, CH2), 3.95 (s, OMe pos. 7), 3.92 (s, OMe pos.
6), 3.78 (s, OMe ester group), 3.43 (triplet-like signal, CH2)
ppm; 13C NMR (80 MHz, CDCl3): d = 186.8 (C=O
ketone), 175.4 (C-4), 166.1 (C=O ester), 151.6 (C-7),
149.4 (C-6), 142.8 (quaternary C in heteroring), 127.2 (C-
8a), 123.9 (C-4a), 118.0 (C-5*), 112.6 (C-8*), 99.9 (=CH-),
98.6 (=CH-), 56.1 (OMe pos. 6 and 7, overlapping signals),
51.8 (OMe ester), 45.1 (NCH2), 36.6 (SCH2) ppm (*inter-
changeable assignments); IR (KBr): vꢀ = 1,712 (C=O
cm-1
.
ester), 1,682 (C=O ketone) cm-1
.
Methyl (Z)-(5,6-dihydro-9,10-dimethoxy-2-oxo-11b-phenyl-
10bH-oxazolo[3,2-d][1,4]benzothiazepin-3(2H)-ylidene)-
acetate (14g, C21H21NO6S)
General procedure for preparation
of oxazolidinobenzothiazine derivatives 14e–14g
1
M.p.: 143–144 °C (from methanol); yield 72%; H NMR
(250 MHz, CDCl3): d = 7.40 (m, H-30,40,50, phenyl), 7.20
(d, H-20,60, phenyl), 7.07 (s, H-8*), 7.05 (s, H-5*), 5.57 (s,
=CH–), 5.20 (m, NCH2, 1H), 3.91 (s, OMe pos. 7), 3.82 (s,
OMe pos. 6), 3.68 (s, OMe ester group), 3.65 (m, NCH2,
1H), 3.30 (s, SCH2, 1H), 2.85 (s, SCH2, 1H) ppm
(*overlapping signals); 13C NMR (80 MHz, CDCl3):
d = 166.6 (C=O ester), 164.4 (C=O lactone), 148.7
(quaternary C in heteroring and C-7, overlapping signals),
148.2 (C-6), 138.1 (C-10, phenyl), 135.7 (C-4a), 128.6 (C-
30,50, phenyl), 128.1 (C-20,60, phenyl), 124.7 (C-8a), 124.3
(C-8a), 117.0 (C-5**), 112.5 (C-8**), 100.8 (=CH–), 87.2
(C-4), 56.0 (OMe pos. 6 and 7, overlapping signals), 51.1
(OMe ester), 49.5 (NCH2), 33.0 (SCH2) ppm (**inter-
changeable assignments); IR (KBr): vꢀ = 1,799 (C=O
Compound 1e–1g (2.5 mmol) was dissolved in aqueous
methanol (25 cm3 methanol and 2 cm3 water), and DMAD
(2.5 mmol) was added. The solution was stirred under
reflux for 5 min and then left to stand for 3 h. The pre-
cipitated dark-red crystals were filtered off and washed
with methanol.
Methyl (Z)-[10b-(2-chlorophenyl)-8,9-dimethoxy-2-oxo-
5H,10bH-oxazolo[3,2-c][1,3]benzothiazin-3(2H)-ylidene]-
acetate (14e, C21H18ClNO6S)
1
M.p.: 159–160 °C (from methanol); yield 66%; H NMR
(250 MHz, CDCl3): d = 7.50 (dd, H-30, 2-chlorophenyl),
7.35 (t, H-40, 2-chlorophenyl), 7.20 (t, H-50, 2-chloro-
phenyl), 7.10 (d, H-60, 2-chlorophenyl), 6.83 (s, H-8), 6.59
lactone), 1,703 (C=O ester), 1,646 (C=C) cm-1
.
123